MtoZ Biolabs Offers a 10% Discount on a Series of De Novo Sequencing Services

In order to support researchers studying in the field of antibody engineering, MtoZ Biolabs now offers a 10% discount on series of de novo sequencing services, including antibody de novo sequencing and protein de novo sequencing. This promotion starts from January 1, 2020 and ends on January 10, 2020.

MtoZ Biolabs is specialized in quantitative multiplexed proteomics and metabolomics applications through the establishment of various spectrometry platforms coupled with high-performance liquid chromatography technology. Based on the high-resolution mass spectrometer Obitrap Fusion Lumos and extensive bioinformatics analysis experience, MtoZ Biolabs has established a new generation of de novo sequencing platform that enables fast and accurate analysis of monoclonal antibody primary sequence, protein sequence and mutation.

De Novo Antibody Sequencing 

Analysis of the primary antibody sequence is the basis for developing antibody-based drugs. However, due to the variation and modification of antibody products, the sequence information of most antibodies is often not included in the available databases. Compared with database dependent traditional methods, de novo sequencing technology uses an advanced data processing algorithm for sequence analysis. Antibody sequence can be accurately analyzed using the de novo sequencing method without database searching. 

“Our platform is suitable for sequence analysis of different subtype antibodies, such as IgG and IgM, and different types of antibodies, including fluorescently conjugated antibodies, immobilized antibodies, and antibodies from different species. ” Said Mrs. Prime Jones, marketing manager of Mtoz Biolabs, Inc.

De Novo Protein Sequencing 

Generally, there are two ways for protein sequence analysis, database search and de novo sequencing. Database search method is unsuitable for analyzing antibodies, peptides, and proteins, of which the sequence information is either inaccessible or not included in any databases. For these cases, de novo sequencing is the only way to decipher the protein sequence. “Coupled with our professional bioinformatics analysis and reverse sequence confirmation, high-quality sequence analysis is guaranteed. ”

Advantage of de novo sequencing:

• Advanced high-resolution mass spectrometry technology
• 100% protein/antibody sequence coverage
• 95% accuracy for sequencing the first amino acid
• Minimum amount of sample required

Original news can be read at

https://www.labsexplorer.com/news/mtoz-biolabs-offers-a-10-discount-on-a-series-of-de-novo-sequencing-services_988 

Comments

Post a Comment

Popular posts from this blog

Practice of N-terminal Sequencing by Edman Degradation Technology in Protein and Peptide Sequence Analysis

Image
The N-terminal amino acid sequence of protein is one of the key quality attributes of biological drugs. N-terminal sequencing by Edman degradation  is a routine method to analyze this property. The analysis of 15 amino acid sequences on the N-terminal by Edman degradation method is usually a necessary item when applying for biological drugs . At  the same time, it is also an annual inspection item of many listed biological drugs (see Pharmacopoeia 2015). In scientific research, N-terminal sequencing can be used to provide key information for the confirmation of unknown or uncertain theoretical sequences. So this method is widely used in scientific research and industry.  W hat are its principles ? H ow to analyze the results ? Advice for sample delivery? P rinciples In short, we can understand it from these two aspects: The first step  is Edman degradation . T hrough the reaction of PITC (Phenylisothiocyanate), an organic reagent, and α - amino acid at the N-terminal of pr
Read more

Part I: Basic Knowledge of Quantitative Analysis of Protein Acetylation Modification

Image
After the protein is translated in the cell, it is processed through a very important step before being transported to the corresponding organelle and undergoing specific biological effects. The role of protein   post-translational modification   ( PTM ) is primarily to alter the activity, localization or function of the protein. Protein PTM  also further increases the diversity and complexity of cellular pathway mechanisms and life activities. Except for acetylation , c ommon protein PTM  include s   phosphorylation , glycosylation , ubiquitination , and the like. Protein  A cetylation  M odification Protein acetylation modification, as the name suggests, refers to the grafting of acetylated groups on the original basis of the protein. In cells, the acetylation modification reaction is catalyzed by an acetyltransferase, and the acetyl group of acetyl-CoA is transferred and added to the protein lysine residue. In earlier studies, acetylation has been considered to be a pos
Read more

De Novo Protein Sequencing Procedures and Features

Image
The sequence of a protein molecule is the basis for the function of a protein. Accurate determinat ion of protein sequence plays an important role in the study of protein functional epitopes, detection of commercial monoclonal antibodies, vaccines, and kits. Although there are many studies on protein sequencing, accurate sequencing of proteins is still not as fast and accurate as that of DNA. Protein sequencing is mainly hampered by the purification of protein samples, and the complexity of factors that make up the amino acid com position of proteins. De novo   protein sequencing  is  also called novel protein sequencing. This technique deduces t he amino acid sequence based on the difference in mass between a series of regular fragment ions generated by the peptide collision with an inert gas. We can guess the amino acid sequence and post-translational modifications based on the y ion and b ion at the cleavage of the peptide bond. De novo  sequencing has a unique advantage that t
Read more